Eugen Steiner
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 10
- Plant-based Medicinal Research 7
- Pharmacogenetics and Drug Metabolism 5
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- Ingar Holme (6 shared papers)Ingmar Jungner (7 shared papers)Are H. Aastveit (3 shared papers)Göran Walldius (4 shared papers)Folke Sjöqvist (6 shared papers)Edoardo Spina (5 shared papers)Leif Bertilsson (2 shared papers)Gunnar Alván (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (9 papers)Therapeutic Drug Monitoring (2 papers)Clinical Chemistry (1 paper)Neurobiology of Aging (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- SwedenUnited StatesNorway
In The Last Decade
Eugen Steiner
25 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Endocrinology, Diabetes and Metabolism 1.1k
- Pharmacology 370
- Cancer Research 399
- Surgery 980
- Cardiology and Cardiovascular Medicine 500
Countries citing papers authored by Eugen Steiner
This map shows the geographic impact of Eugen Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugen Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugen Steiner more than expected).
Fields of papers citing papers by Eugen Steiner
This network shows the impact of papers produced by Eugen Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugen Steiner. The network helps show where Eugen Steiner may publish in the future.
Co-authors
The 25 scholars most cited alongside Eugen Steiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Hit paper breakdown → | 2001 | 975 |
| 2 | 2002 | 473 | |
| 3 | 1998 | 131 | |
| 4 | 1985 | 112 | |
| 5 | 1988 | 107 | |
| 6 | 1984 | 73 | |
| 7 | 1992 | 71 | |
| 8 | 1988 | 60 | |
| 9 | High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. | 1992 | 49 |
| 10 | 1987 | 44 | |
| 11 | 1998 | 40 | |
| 12 | 1987 | 40 | |
| 13 | 1971 | 26 | |
| 14 | 1988 | 20 | |
| 15 | 1990 | 17 | |
| 16 | 1987 | 15 | |
| 17 | The Slovak dilemma | 1973 | 11 |
| 18 | 1985 | 10 | |
| 19 | 1982 | 8 | |
| 20 | 1989 | 7 |
About Eugen Steiner
Eugen Steiner is a scholar working on Pharmacology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery and Oncology, having authored 25 papers that have together received 2.3k indexed citations. Recurring topics across this work include Plant-based Medicinal Research (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Epilepsy research and treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Pharmacology (370 citations), Cancer Research (399 citations), Surgery (980 citations) and Cardiology and Cardiovascular Medicine (500 citations). Eugen Steiner has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Ingar Holme, Ingmar Jungner, Are H. Aastveit, Göran Walldius, Folke Sjöqvist, Edoardo Spina, Leif Bertilsson, Gunnar Alván, Christer von Bahr and Lennart Iselius. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Therapeutic Drug Monitoring, Clinical Chemistry, Neurobiology of Aging and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.